Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monocloncal Antibody

NCT03183024 is registered in ClinicalTrials.gov with Jonathan A. Bernstein, MD as lead sponsor.

NCT NCT03183024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monocloncal Antibody
Lead sponsor
Jonathan A. Bernstein, MD
Phase
Phase 4
Overall status
Completed
Start date
September 12, 2017
Completion date
November 6, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic urticaria